Lucentis® using Visudyne® study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration
Eric Chen, David M Brown, Tien P Wong, Matthew S Benz, Eric Kegley, Joel Cox, Richard H Fish, Rosa Y KimRetina Consultants of Houston, Texas, USAPurpose: Combination verteporfin photodynamic therapy (vPDT) and antivascular endothelial growth factor (anti-VEGF) therapy may decrease the need for injec...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-09-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/lucentisreg-using-visudynereg-study-determining-the-threshold-dose-flu-a5314 |